Try our Advanced Search for more refined results
Life Sciences - October, 2024
284 articles
- Judge 'Duped' By BigLaw Attys Urged To Preserve Sanctions
- IP Forecast: Another Apple Watch Trial Kicks Off In California
- NY Court Urged To Reject 'Audacious' Shareholder Test Cases
- CVS Unit Exec's Ex-Partner Charged With Insider Trading
- Drug Cos. To Pay $49M For State-Led Generic Pricing Claims
- Masimo Sues Ex-CEO Over 'Unprecedented' $450M Demand
- Purdue Gets More Time For Deal, 'Substantial' Progress Made
- Flint Water Case Paused For 'Advanced' Settlement Talks
- Judge Upholds Sanctions Against Ex-Stimwave CEO
- How Judiciary Can Minimize AI Risks In Secondary Sources
- Newly Acquired Information Can Be Key In Drug Label Cases
- The 2024 Law360 Pulse Leaderboard
- Firms' Hiring Strategies Are Evolving In Fight For Top Spot
- Teva Fined €463M For Blocking Rival MS Drug Launch
- FDA Didn't Flub Approval In Orphan Drug Case, DC Court Says
- Alleged Kickback Plotters Can Waive Conflict Over Attorney
- Cigna Wants $16.1M, Florida Labs Seek $5.1M In Benefits Feud
- LA Times Owner Faces Investor Suit Over Drug Co.'s Woes
- After Exeltis Win, Judge Won't Allow Suits On Dropped Patents
- Publix Denied Early Win Over Opioid Coverage Defense
- 3rd Circ. Told Medicare Drug Price Talks Not Voluntary
- Biopharma Co. Can't Knock Ex-CFO's Bias Suit Out Of Court
- Ex-Takeda Exec. Gets Nearly 4 Years For Fake Invoice Scam
- Yale Researcher's Suit Over Loss Of 'Life's Work' Transferred
- Ohio PBM Case Will Wait For High Court Ruling
- DLA Piper's FDA Regulation Vice Chair Joins White & Case
- Nvidia Case's Potential Impact On Securities Class Actions
- How Attorneys Can Break Free From Career Enmeshment
- NY Judge Tosses $14B Decongestant MDL
- Y-mAbs Therapeutics Investors Get Final OK For $19.7M Deal
- Retired Fed. Circ. Judge Backs Invisalign In Monopoly Cases
- Patent Partner Moves From King & Spalding To Steptoe
- 4th Circ. Quizzes Drugmaker Challenging W.Va. Abortion Law
- Biopharma Co. Escapes Investor Suit Over Drug Approval Lies
- Medical Co. Gets No Coverage For Toxic Tort
- Investors Float $21M Deal To End Life Sciences SPAC Suit
- Beyond Abortion, 7 Ballot Questions Set To Shape Care
- Allergan, Mankind Settle IP Fight Over Lumigan Generic
- Purdue Creditors Can Sue Sacklers For $11.5B
- Pa. DA Says ATF's Pot Patients Ban Doesn't Fit With Bruen
- Senate Panel Targets 'Clever' Pharma Pricing
- Key Healthcare Issues That Hinge On The Election Outcome
- Patent Lessons From 4 Federal Circuit Reversals In September
- Circuit Judge Rips Atty's 'Unearned Windfall' In Liability Case
- Crescent Inks Oncology Merger With $200M In Private Funding
- PE-Owned Implant Maker Plagued By Lawsuits Hits Ch. 11
- Lawyers With Disabilities Are Seeking Equity, Not Pity
- Masimo Sues Founder Over Alleged 'Empty Voting' Scheme
- Sterigenics Says Residents Can't Tie Harms To Ethylene Oxide
- Flint Bellwether Delayed On Eve Of Trial, Again
- Judge Leaves Patent Case After Fed. Circ. Undoes Ruling
- Judge Tosses Hearing-Loss MDL Bellwether With Voided Law
- Moderna Brass Hit With Investor Suit Over RSV Shot Claims
- Pfizer Urges Court Not To Ax Delay Defense In Vax IP Fight
- Mass. Court's Wiretap Ruling May Be Bad Omen For Plaintiffs
- AbbVie Paying $1.4B For Alzheimer's-Focused Biotech
- Medical Laser Co. Seeks Multiplier For Rival's 'Deceitful' Raid
- Judicial Committee Best Venue For Litigation Funding Rules
- Crown Settles Customer Dispute To Close $924M Revance Buy
- Inari Wins Bid To Kill Plant Gene Patent At PTAB
- Vidal Warned Of 'Heightened' Burden, 'Loophole' In Seed Fight
- NJ Ethics Board Faces Contempt Bid In Retaliation Fight
- Feds Seek 6½ Years For Ex-Takeda Worker Over Invoice Fraud
- High Court Bar's Future: Mitchell Law's Jonathan F. Mitchell
- Pharmacy Must Pay $39.2M In Conn. Kickback Case
- The Strategic Advantages Of Appointing A Law Firm CEO
- UK Litigation Roundup: Here's What You Missed In London
- FTC Official Doubts Election Will Deter Antitrust 'New Era'
- Del. Co. Tells 3rd Circ. €4.2M Award Was Properly Denied
- IP Forecast: Inhibrx Co-Founder Faces Biotech Secrets Trial
- 7th Circ. Doubts Satanic Temple Can Wage Abortion Fight
- Sen. Presses US Trade Rep To Take Up Fentanyl Probe
- 'Will Of The People' Upheld With Ohio Abortion Ban Quashed
- PBMs Want Separate FTC Hearings Over Insulin Prices
- Bayer Hit With False-Ad Suit Over Malic Acid In Vitamins
- How 2 Proposed Bills Could Transform Patent Law
- ITC Bans Foreign Counterfeit Tourniquets
- Mass. Justices Reject Meta, Google 'Wiretap' Claims
- Beekeeping Makes Me A Better Lawyer
- Late Smoker's Spouse Can Argue Survivor's Benefits At Retrial
- NM Pot Cos. Say Border Agents Wrongfully Seized Product
- SoClean Says Philips Can't Stand In For Damaged CPAP Users
- Budding Lessons From Landmark Plant Seed Patent Battle
- Merck Bets More Than $1B On Yale Cancer Treatment Spinout
- Former Axinn Hatch Waxman Attys Team Up At Polsinelli
- Roche CEO Says Novo-Catalent Deal Should Be Blocked
- Suit Over Wash. Ban On 'DIY' Rape Evidence Kits Nixed
- Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection
- Biotech Cos. Keep Dancing Despite Purple Book Disclosures
- IQVIA, Veeva Blast Summary Judgment Bids In Secrets Suit
- Ark. Supreme Court Voids Nov. Effort To Expand Medical Pot
- Patent Office Finds Public Engagement Leader
- The Key To Solving High Drug Costs Is Understanding Causes
- Judge Skeptical Amgen Can't Sue Over Colo. Drug Price Caps
- LA-Based Wound Group Hits Ch. 11 After Medicare Pay Pause
- NJ Justices Create Mass Tort Track For Bard Catheter Suits
- Legal Institutions Must Warn Against Phony Election Suits
- Bring Back Patent Models To Shut Down The Patent Trolls
- How Law Firms Get And Keep Elite Status
- The 2024 Prestige Leaders
- In-House Counsel For Veeva, SingleStore Joins Stoel Rives
- Eli Lilly Slams 'Dangerous' Knock-Off Weight Loss Drugs
- Apple Tells Del. Jury It Wants Smartwatch Infringing To Stop
- FDA Tells Court Menthol Cigarette Ban Is Still Under Review
- PBMs Keep Door Open To Constitutional Riposte Against FTC
- GOP Pols Want Probe Into FDA Laboratory Safety
- Novartis Loses Challenge To Medicare Drug Price Talks
- Strategies To Avoid Patent Issues In AI Drug Discovery
- Goodwin Steers Biotech Firm Septerna's Plans For $175M IPO
- McGuireWoods Adds Healthcare Atty From Cooley In NY
- How Cos. Can Build A Strong In-House Pro Bono Program
- Bristol-Myers Win Offers Lessons For Debt Security Holders
- Catalent CEO Defends Novo Deal, Will Stay On After Buyout
- Law360 MVP Awards Go To Top Attys From 74 Firms
- What Attorneys Expect From Harris And Trump On Patents
- Chancery Keeps Better Therapeutics SPAC Suit Alive
- Fed. Circ. Won't Question Reviving Vascepa Skinny Label Row
- Cigna Says Florida Labs Owe $16M After 'Cheating' For Benefits
- Teva Signs Deal With Indirect Buyers In Effexor Antitrust Suit
- Biotech Co. Wins Injunction Against Ex-Worker In Secrets Suit
- Home Canning Makes Me A Better Lawyer
- Navigating The Bankruptcy Terrain After Purdue Pharma
- 5 Considerations For Obviousness-Type Double Patenting
- Taxation With Representation: Baker, Simpson, Ropes
- Philly Atty Suspended After Guilty Plea In Pill Mill Scheme
- FTC Faces More Pressure To Block $16.5B Novo-Catalent Deal
- Pfizer Escapes 401(k) Fee Suit Due To Poor Comparisons
- E-Cig Regs Are Congress' Job, Not FDA's, GOP Pols Tell Justices
- 'More Honesty' Needed In Philips IP Row, Judge Says
- Justices Urged To Fix 'Novel Misreading' Of IP Safe Harbor
- Northwestern Hits Moderna With Patent Suit Over COVID Vax
- Amgen Faces Derivative Suit In Del. Over Tax Disclosures
- Oregon Appeals Court Says E-Cig Rules Violate Free Speech
- $20B Verizon-Frontier Deal Faces Scrutiny, And Other Rumors
- Ex-Genzyme Exec Says Anxiety Disclosure Led To Firing
- Moderna Wants Fees For 'Frivolous' COVID-19 Vax Suit
- Patent Lessons From 7 Federal Circuit Reversals In August
- Use The Right Kind Of Feedback To Help Gen Z Attorneys
- Philips Says $12M Sanction Needed For Evidence Destruction
- Apple Heart Rate Monitor Patent Survives PTAB
- Direct Buyers Get Final OK For $44M Drug Price-Fixing Deal
- Pharma Co. Contractor Settles SEC Insider Trading Claim
- Ex-Pharma Co. Employee Traded On GSK Deal Info, SEC Says
- Congress Can And Must Enact A Supreme Court Ethics Code
- SEC To Settle Claims CBD Exec Took $13M From Hospital
- Caremark, Optum Say FTC Insulin Case Gets PBMs All Wrong
- Houston Pharma Exec Found Guilty In $160M Health Fraud
- AAM, Alvogen Back Sun Pharma In Double Patenting Row
- M&A Pros Cautious About Expected Private Equity Surge
- The Pop Culture Docket: Justice Lebovits On Gilbert And Sullivan
- Horizon Lodges 4-Fold Attack On Tepezza MDL Bellwethers
- Judge Backs Exelixis Cancer Drug Patent Claims
- Motley Rice May Avoid DQ In Boston Opioid Case, Judge Hints
- GSK Says Moderna's COVID, RSV Vax Infringe MRNA Patents
- New HHS Research Misconduct Rules Bring Seismic Changes
- Justices Mull RICO's Scope In Trucker's CBD Case
- Walmart, Execs Settle Chancery Opioid Suit For $123M
- Novartis To Appeal Ruling In Entresto Generic Drug Fight
- Feds Cut Whistleblowers Out Of Kickback Deal, Court Told
- Skadden Picks Up Arbitration Co-Head From Sidley In Asia
- Law Firms Diverge As Anti-ESG Pushback Continues
- The 2024 Law360 Pulse Social Impact Leaders
- Ill. Home Health Kickbacks Ruling Intact After Justices Pass
- Baker McKenzie Leads Lundbeck's $2.6B Deal For US Pharma
- Pharmacist Gets Up To 15 Years In Mich. For Fatal Outbreak
- High Court's TCPA Grant Set To Broaden Loper Bright's Blow
- Apotex Accused Of Infringing Novo Nordisk Diabetes Drug
- Up Next At High Court: CBD Injuries & The Clean Water Act
- Apple Watch Patents Dodge Ax As Masimo Jury Trial Nears
- Medytox Loses ITC Fight Over Antiwrinkle Trade Secrets Use
- Texan Who Sued Ex's Colleagues Over Abortion Drops Suit
- J&J Should Pay $30M For Developer's Cancer, Conn. Jury Told
- Justices Will Evaluate RICO Scope In Trucker's CBD Case
- Swiss Officials Clear Novartis IP Suits As 'Common Practice'
- 9th Circ. Backs Planned Parenthood's $14M Atty Fee Win
- 'Bloodsport' Poaching Case To Mediate After Disputed Verdict
- UK Litigation Roundup: Here's What You Missed In London
- State Of The States' AI Legal Ethics Landscape
- Animal Medication Co. Sued Over Dog Arthritis Treatment Risks
- Federal Policy Can't Kill Psilocybin Access Suit, Court Told
- How Biden Admin Has Used Antitrust Tools, And What's Next
- Biotech Co. Gritstone Hits Ch. 11 With Over $100M Debt
- Target Made Inflated Claims About Gas Pills, Shoppers Allege
- Teva To Pay $450M To Settle Kickback Cases
- Defining All-Risk: Despite $30M Loss, Loose Bolt Not 'Damage'
- Sen. Warren, Novo At Odds On Merits Of $16.5B Deal
- Pfizer Threatened To Sue Former Execs, Starboard Says
- The Shifting Role Of Patent Attorneys In The Age Of AI
- Hyundai Plans IPO For Indian Biz, Plus More Rumors
- 8 Childhood Lessons That Can Help You Be A Better Attorney
- CVS, United Health Seek Removal Of FTC's Khan In PBM Case
- Philips Preserves Lanham Act Counterclaim In CPAP Cleaner MDL
- Companies' Kratom Supplements Are Addictive, Class Says
- DLA Piper Adds Former Faegre Drinker Litigator In Philly
- GSK Settles Nearly All State Zantac Cases For Up To $2.2B
- Lead Test Maker Vows Compliance As $42M Deal Approved
- Medical Device Service Co. Hits Ch. 11 After Fight With Rival
- This Election, We Need To Talk About Court Process
- Apple Loses Bid For Jury Trial In Masimo Trade Secrets Fight
- Illumina Wants Unresponsive Plaintiff To Pay $200K, Atty Fees
- Ropes & Gray Attys Chided For Wielding Excessive Footnotes
- Jackson, Kagan Target Loper Bright In Ghost Gun Case
- Fed. Circ. Mulls Trade Dress Fight Over Pink Hip Devices
- 2nd Circ. Won't Revive 1-800 Contacts, Warby Parker Row
- CooperSurgical Fails To Escape Embryo Solution Recall Suits
- Elanco Misled Investors About Dog Medicine Safety, Suit Says
- 3rd Circ. Directs Court To Explain If Natera Ads 'Literally False'
- 3rd Circ. Preview: Constitutional Rights Fears Top October
- J&J Greenwashes '100% Plant-Based' Wipes, Suit Says
- A Look At The PTAB's Assessment Of Prior Art Exceptions
- Doctor Wants New Trial In $16.4M Suit Over Patient's Suicide
- Playing Diplomacy Makes Us Better Lawyers
- College Admins Beat Ex-Prof's Suit Over Race-Based Study
- 9th Circ. Asked To Take Another Look At 'Patent Misuse' Case
- AbbVie's Top Brass Escape Suit Over Rinvoq Claims, For Now
- Boehringer Defends Zantac As Cancer Jury Trial Kicks Off
- ITC Judge Pushes For Import Ban In Liver Drug Secrets Row
- Fed. Circ. Questions If Safer OxyContin Profits Came From IP
- Merck Immune For 'Inflated' Vax Claims To FDA, 3rd Circ. Says
- Biotech, Medical Device Firms Prep Three IPOs Totaling $376M
- Mich. Supreme Court Snapshot: Insulin Prices, Disney Audit
- Mylan, Novo Nordisk Settle Ozempic Patent Dispute
- 5 Decisions To Know By Outgoing Mass. Chief Judge
- Trio Of 1st Circ. Criminal Cases Turned Away By Top Court
- How Patent Litigation Is Changing Amid Decline In Filings
- Justices Won't Hear Kickback Statute 'Willfulness' Case
- High Court Rejects Pleas To Hear 7 Patent Cases
- High Court Won't Look At Alabama Frozen Embryo Decision
- Justices Won't Hear Shkreli's Bid To Undo $64M Disgorgement
- Top 5 Supreme Court Cases To Watch This Fall
- NJ, Ethics Board Must Hand Over Docs In Retaliation Fight
- DOJ Charges Execs, Sales Reps Over Texas 'Pill Mills' Sales
- Regeneron Can't Ax Willful Infringement In COVID Patent Case
- Healthcare Co. Inks Deal In DOL Equal Pay Investigation
- There May Not Be Life On Mars, But There Could Be IP
- Mental Health First Aid: A Brief Primer For Attorneys
- UK Litigation Roundup: Here's What You Missed In London
- High Court Takes Up E-Cig 'Forum Shopping' Appeal
- High Court Will Hear TCPA Case Over Online Junk Faxes
- Gilead Makes Generic HIV Drug Plan, Advocates Urge Expansion
- Boston Pharma Co. Drops Another Moderna Patent Suit
- Del. Vice Chancellor Slams Fee Terms In Advancement Case
- Trulieve Sues Fla. Republican Party Over Anti-Weed Ads
- FibroGen Suit Alleging Disclosure Failures Tossed In Del.
- 12 Lawyers Who Are The Future Of The Supreme Court Bar
- Stanford Profs Deny Roche's Trade Secret Theft Accusations
- FTC's Report Criticizing Drug Middlemen Is Flawed
- Texas Takes Aim At Insulin Manufacturers For Price-Gouging
- Flint Water Judge Wishes Public Knew Case Complexity
- NJ Contractors Accused Of $10M Fraud In Lead Removal Work
- Cos. Want Federal Rule On Litigation Funding Disclosure
- Ex-US House Energy Committee Atty Joins Foley In DC
- CVS Pushed To Unwind Aetna Megadeal, And Other Rumors
- Collecting Art Makes Me A Better Lawyer
- Bard Agrees To Individualized Deals In Hernia Mesh Litigation
- Chancery To Mull Receiver In Drug Co. Consulting Bill Row
- Pfizer Didn't Warn Of Tumor Risks In Depo-Provera, Suit Says
- Avadel Tells Fed. Circ. It Should Be Free To Test Sleep Drug
- Amarin Says Sky Isn't About To Fall In Skinny Labels Fight
- Doctor Cops To Dealing Ketamine That Killed Matthew Perry
- Dental Laser Maker Biolase Hits Ch. 11 With $33M In Debt
- Del. Dispatch: Cautionary Tales Of 2 Earnout Effort Breaches
- Supplement Co. Hits Back At TM Suit, Alleges Fake Reviews
- Takeaways From Novo Nordisk's Fight For Market Exclusivity
- GNC Wins $45M In Awards Against Asian Franchisees
- Fla. Atty Disbarred For Abandoning Pharma Biz Before USPTO
- ExecuPharm Agrees To Pay Ransomware Victims $10K Each
- Using Primacy And Recency Effects In Opening Statements
- Secret Service Failures Offer Lessons For Private Sector GCs
- Bill Is Key To Protecting US Economy From Patent Piracy
- Teva Sales Workers Get $2.7M Unpaid OT Deal Approved
- From AI To Enviro: The Top Biz Bills Calif. Gov. Inked Into Law
- 9th Circ. Cites 'Sunscreen' Song In Reviving Banana Boat Suit
- Judge Backs Louisiana 340B Law In Loss For Pharma Lobby
- Activists Sue Ark. Officials Over Medical Pot Ballot Measure
- Ex-CBD Exec Must Face SEC Fraud Suit Over $13M Deal
- DOJ Says It Is Constitutional To Disarm Pot Patients
- Amgen Must Face Suit It Misled Investors On $10.7B Tax Bill
- Biotech Investors Reach $32.5M Deal Over Failed COVID Test
- Defending AI, Machine Learning Patents In Life Sciences
- WilmerHale Lands Latham Life Sciences Ace In Bay Area
- Litigation Inspiration: Honoring Your Learned Profession
- From Concept To Capital: 5 Stages Of Evolving IP Needs
- Nostrum Labs Hits Ch. 11 A Year After Medicaid Settlement